Professor David Durrheim: Ledger

Stories naming Professor David Durrheim. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Role	Organisation	Sources
Chair	Western Pacific Measles and Rubella Regional Verification Commission	Brandon Capital portfolio, Brandon BioCatalyst portfolio
Professor	University of Newcastle	Brandon Capital portfolio, Brandon BioCatalyst portfolio

Grant $7.5m

Vaxxas Awarded US$5 million Grant for Clinical Study of Measles and Rubella Vaccination

Vaxxas received a Gates Foundation grant to run first-in-human trials of its microneedle patch vaccine for measles and rubella, building on an earlier preclinical grant from the same funder.

Brandon BioCatalyst portfolio Wed 18 Mar 2020 Vaxxas University of Newcastle Western Pacific Measles and Rubella Regional Verification Commission Gates Foundation Professor David Durrheim Dr David L Hoey

Also Brandon Capital portfolio

Professor David Durrheim

Roles

Coverage

Vaxxas Awarded US$5 million Grant for Clinical Study of Measles and Rubella Vaccination